Evidence map›Paper›PMID 32958715›Full record

ArticleAntimicrobial agents and chemotherapy2020

Imipenem plus Fosfomycin as Salvage Therapy for Vertebral Osteomyelitis.

Itaru Nakamura, Tetsuo Yamaguchi, Kotaro Aoki, Yuri Miura, Satoko Sato, Hiroaki Fujita, Hidehiro Watanabe

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Itaru NakamuraDepartment of Infection Prevention and Control, Tokyo Medical University Hospital, Tokyo, Japan.
Tetsuo YamaguchiDepartment of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University, Tokyo, Japan tetsuo.yamaguchi@med.toho-u.ac.jp.ORCID 0000-0002-6220-1890
Kotaro AokiDepartment of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University, Tokyo, Japan.ORCID 0000-0002-9237-1217
Yuri MiuraDepartment of Infection Prevention and Control, Tokyo Medical University Hospital, Tokyo, Japan.
Satoko SatoDepartment of Infection Prevention and Control, Tokyo Medical University Hospital, Tokyo, Japan.
Hiroaki FujitaDepartment of Infection Prevention and Control, Tokyo Medical University Hospital, Tokyo, Japan.
Hidehiro WatanabeDepartment of Infection Prevention and Control, Tokyo Medical University Hospital, Tokyo, Japan.
Tokyo Medical University Hospital · JPToho University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We applied combination antibiotic therapy to treat vertebral osteomyelitis and a psoas abscess caused by glycopeptide-intermediate (MIC, 2 μg/ml) and daptomycin-nonsusceptible (>2 μg/ml) methicillin-resistant

Indexed as

FosfomycinMethicillin-Resistant Staphylococcus aureusOsteomyelitisStaphylococcal InfectionsAnti-Bacterial AgentsHumansImipenemMicrobial Sensitivity TestsSalvage TherapyAnti-Bacterial AgentsFosfomycinImipenemantibiotic combinationEtest synergy testfosfomycinimipenemwhole genome analysis

Identifiers

PMID32958715
PMCPMC7927830
OpenAlexW3087519969

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.